Establishment Labs Holdings Inc. (ESTA)
Establishment Labs Holdings Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Austin, TX, US. The stock last traded at $75.02, up 1.00% on the session, giving a market capitalisation of $2.21B. On trailing twelve-month figures it carries a trailing P/E of -57.34, a net margin of -15.8%. Its beta of 1.09 implies it has historically moved more than the broad market.
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
Establishment Labs Holdings Inc. is most often compared with the following Healthcare names: